Question Title

* 1. Check appropriate title.

Question Title

* 2. Please rate your overall satisfaction with the organization of this meeting.

Question Title

* 3. The ACCME defines commercial bias as presentations giving an unbalanced view of therapeutic options by promoting a specific proprietary business interest of a commercial interest.

Was this CME course free of commercial bias?

Question Title

* 4. Did the faculty disclose significant relationships with commercial support?
(One or more of these methods: Syllabus / Opening Remarks / Verbally / On Slides)

Question Title

* 5. Please rate the quality of the meeting facilities.

Question Title

* 6. How well were the 2017 David A. McQueen Memorial Perspectives in Total Joint Arthroplasty: The Hip & Knee course Learning Objectives met?

Upon completion of the course participants should be able to:

  Significantly Met Somewhat Met Not Met
Identify indications for primary and revision arthroplasty
Recognize clinical results and general problems with arthroplasty techniques as well as those specific to implant materials and design
Evaluate new treatment options for complete total knee arthroplasty (TKA) and methods for diagnosis and treatment
Identify indications for primary and revision hip arthroplasty
Recognize clinical results and general problems with hip arthroplasty techniques as well as those specific to implant materials and design
Evaluate new treatment options for complete total hip arthroplasty (THA) and methods for diagnosis and treatment

Question Title

* 7. Did you meet your personal goal/objective for what you intended to get out of this course?

Question Title

* 8. Do you intend to integrate what you learned at this conference into your current practice?

Question Title

* 9. Please rate the relevance of this program to your scope of practice:

Question Title

* 10. Please rate the OVERALL EFFECTIVENESS of each of our 2017 David A. McQueen Memorial Perspectives in Total Joint Arthroplasty: The Hip & Knee Course speakers
SESSION I

  Excellent Very Good Good Fair Poor
Anthony K. Hedley, MD, FRCS - The Painful THA
Tarun Bhargava, MD - Tracking Opioid Use in Private Practice
Kirby D. Hitt, MD - Managing Acetabular Bone Loss in Revision Total THA
Bradley R. Dart, MD - Total Hip Arthroplasty as Initial Management for Acetabular Fracture
J. Christopher Banwart, MD - Trunionosis & Metal Ion Disease-Head Revision vs. Entire Femoral Revison
Robert P. Cusick, MD - Hip Resurfacing – Still An Option
David W. Anderson, MD - Revision TKA: Exposure and Implant Removal

Question Title

* 11. Please rate the OVERALL EFFECTIVENESS of each of our 2017 David A. McQueen Memorial Perspectives in Total Joint Arthroplasty: The Hip & Knee Course speakers
SESSION II: The Difficult Primary Total Knee and Total Hip: Case-Based Presentations Panel

  Excellent Very Good Good Fair Poor
J. Christopher Banwart, MD
Kenneth A. Greene, MD
Anthony K. Hedley, MD, FRCS 
Kirby D. Hitt, MD 
Viktor E. Krebs, MD 

Question Title

* 12. Please rate the OVERALL EFFECTIVENESS of each of our 6th ANNUAL ICJR SHOULDER COURSE speakers
SESSION III

  Excellent Very Good Good Fair Poor
Bradley R. Dart, MD - Femoral Acetabular Impingement
Thomas L. Bradbury, MD - Modified Frailty Index: A Quick & Easy Predictor of Poor Outcome for THA & TKA
Kirby D. Hitt, MD - Balancing the Severe Varus/Valgus Knee
Kenneth A. Greene, MD - Managing Instability in TKA
Anthony K. Hedley, MD, FRCS - Osteotomy and TKA
Viktor E. Krebs, MD - Peri-Prosthetic THA Fractures-Evaluation and Management in 2017
Tarun Bhargava, MD - Cost Containment in Revision THA and TKA

Question Title

* 13. Please rate the OVERALL EFFECTIVENESS of each of our 2017 David A. McQueen Memorial Perspectives in Total Joint Arthroplasty: The Hip & Knee Course speakers
SESSION IV: Panel: Managing the TJA Bundle: Strategies and Lessons

  Excellent Very Good Good Fair Poor
Kenneth A. Greene, MD 
Kirby D. Hitt, MD 
Viktor E. Krebs, MD 
Ryan M. Nunley, MD

Question Title

* 14. Based on your CME needs, please give suggestions for future program topics/formats.

Question Title

* 15. What barriers do you foresee that may hinder your implementation of changes learned at this activity? What educational strategies could help to overcome these barriers?

Question Title

* 16. What do you see as your BIGGEST challenge in improving patient safety, patient care and/or patient outcomes? What educational strategies could help to overcome this challenge?

Question Title

* 17. How did you hear about this CME Program?

Question Title

* 18. Please provide your contact information.

Question Title

* 19. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Foundation for Orthopaedic Research and Education (FORE) and International Congress for Joint Reconstruction (ICJR).

FORE is accredited by the ACCME to provide continuing medical education for physicians. FORE designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please attest below to the number of credits earned during this activity (min 0.25 - max 11.25)

T